Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
Federica Fogacci, Young Fellow at European Atherosclerosis Society, shared on LinkedIn:
”On 17 November, I had the pleasure of taking part in the EAS Lipoprotein(a) Workshop, organized by the European Atherosclerosis Society with the support of Novartis and Fondazione SISA.
It was a highly stimulating opportunity to share experiences on the role of Lp(a) in cardiovascular risk and to further strengthen collaboration within the Lp(a)CCELERATE study.
I left the meeting with clearer ideas, fresh perspectives and – above all – the feeling of being part of a community of colleagues genuinely committed to improving CvPrev
Many thanks to the organizers and to all participants for their questions, insights and openness in building the next steps of this journey together.”
Stay updated with Hemostasis Today.
-
Sep 1, 2026, 18:13Ramsha Batool: Chemotherapy-Induced Anemia Impacts Quality of Life in Breast Cancer
-
Sep 1, 2026, 18:09Natalya Shynhera: Using Anemia to Teach Medical English in Real Clinical Practice
-
Sep 1, 2026, 18:06Wei Du: New Therapeutic Potential for PARP Inhibitors in MLL-Rearranged Leukemia
-
Sep 1, 2026, 18:03Tobias Tichelbäcker: PRAGUE-26 Shows Catheter Lysis Beats Anticoagulation Without Ultrasound
-
Sep 1, 2026, 18:00Baptiste Thibault: My First Publication as First Author on Ionized Calcium Monitoring Before Citrate-CRRT
-
Sep 1, 2026, 17:51Nadezhda Vasilyeva: Shifting the Boundaries of Acute Ischemic Stroke Management
-
Sep 1, 2026, 17:49Malik Ghannam: Recent Venous Thrombosis Risk Factors May Help Explain Cryptogenic Stroke in Young Adults
-
Sep 1, 2026, 17:42Rishabh Jain: Renal Artery FMD Is Managed With Balloon Angioplasty Alone
-
Sep 1, 2026, 17:42Caitlin R: The Brain’s Need to Find Patterns